Skip to content

Complete immunisation schedules

All information is correct at the time of publication.
Date published: 1 January 2026

The childhood immunisation schedule in Wales changed on 1 January 2026 

See the schedule below, or for more information about these changes and to check your child’s eligibility go to: Changes to the childhood immunisation schedule.

The complete routine immunisation schedule for Wales from January 2026

Age due Diseases protected against Vaccine Name Usual site
8 weeks old Diphtheria, tetanus, pertussis (whooping cough), polio, haemophilus influenzae
type b (Hib) and hepatitis B
DTaP/IPV/Hib/ HepB (6-in-1) Infanrix hexa® or Vaxelis® Thigh
8 weeks old Meningococcal group B (MenB) MenB Bexsero® Thigh
8 weeks old Rotavirus gastroenteritis Rotavirus Rotarix® By mouth
12 weeks old Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B DTaP/IPV/Hib/ HepB Infanrix hexa® or Vaxelis® Thigh
12 weeks old Meningococcal group B (MenB) MenB Bexero® Thigh
12 weeks old Rotavirus gastroenteritis Rotavirus Rotarix® By mouth
16 weeks old Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B DTaP/IPV/Hib/ HepB Infanrix hexa®or Vaxelis® Thigh
16 weeks old Pneumococcal PCV 13 Prevenar 13®1 Thigh
12 months old Pneumococcal PCV 13 Prevenar 13®1 Upper arm/ thigh
12 months old Meningococcal group B (MenB) Men B Bexero® Upper arm/ thigh
12 months old Measles, mumps and rubella MMR ProQuad® or Priorix-Tetra® Upper arm/ thigh
18 months old Born before 1 July 2024: No appointment
Born on or after 1 July 2024: Measles, mumps and rubella
MMR ProQuad® or Priorix-Tetra®  Upper arm/thigh
18 months old Born before 1 July 2024: No appointment
Born on or after 1 July 2024: Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B
DTaP/IPV/Hib/HepB (6-in-1) Infanrix hexa® or Vaxelis® Upper arm/thigh
22 and 3 years old and all school aged children Influenza (annually from September) Live attenuated influenza vaccine Fluenz®3 Both nostrils
3 years 4 months old Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B dTaP/IPV (4-in-1) Boostrix-IPV® or Repevax® Upper arm
3 years 4 months old Born before 1 January 2025: Measles, mumps and rubella

Born on or after 1 January 2025: No MMRV vaccine
MMRV ProQuad® or Priorix-Tetra® Upper arm
School year 8
(12 to 13 year olds)
Cancers and genital warts caused by specific human papillomavirus (HPV) types HPV4 (one dose) Gardasil 9® Upper arm
School year 9
(13 and 14 year olds)
Tetanus, diphtheria and polio Td/IPV (3-in-1) (check MMR status) Revaxis® Upper arm
School year 9
(13 and 14 year olds)
Meningococcal groups A, C, W and Y MenACWY Nimenrix® or MenQuadfi® Upper arm
65 years of age and older Influenza (annually) Inactivated influenza vaccine Adjuvanted trivalent influenza vaccine (aTIV) 

or

Cell-based trivalent influenza vaccine (TIVc)5
Upper arm
65 years of age Pneumococcal PPV23 or PCV206 Pneumovax 23® or Prevenar 20® Upper arm
65 years old and 70 to 79 years old 

(plus people from age 18 with severe immunosuppression)7
Shingles Shingles Shingrix® Upper arm
75 years  Respiratory Syncytial Virus (RSV)  RSV Abrysvo® Upper arm

1 Refer to the Green Book Chapter: Pneumococcal – table 25.3 (external site) for babies with asplenia, splenic dysfunction, complement disorder or severely immunocompromised. 

2 Children must be 2 years old by 31 August to receive influenza vaccine in the routine programme in autumn/winter

3 If Fluenz® is unsuitable, use inactivated flu vaccine.

4 Check the relevant chapter of the Green Book for individuals requiring a 3-dose schedule. 

5 Only use TIVc if no aTIV stock is available or if aTIV is unsuitable. ​​​​​​​

6 PCV20 is expected to replace PPV23 in early 2026.

Selective immunisation programmes

Target group Age and schedule Disease Vaccines
Babies born to hepatitis B infected mothers At birth and 1 month old1 Hepatitis B Hepatitis B vaccines
(Engerix B® / HBvaxPRO®)
Infants in areas of the country with TB incidence >= 40/100,000 From birth Tuberculosis BCG®
Infants with a parent or grandparent born in a high incidence country2 From birth
Tuberculosis
BCG®
People in a risk group for influenza3 From 6 months to 64 years Influenza Age-appropriate flu vaccine3
Pregnant women From 16 weeks of pregnancy Pertussis Tdap (ADACEL®) 

If ADACEL® is unavailable or contraindicated, administer dTaP/IPV (Boostrix-IPV® or Repevax®)
Pregnant women From 28 weeks of pregnancy  Respiratory syncytial virus (RSV) Abrysvo®
Pregnant women At any stage in pregnancy during the flu season Influenza Recommended inactivated flu vaccine3
Gay, bisexual and other men who have sex with men 45 years of age and under4
HPV4 Gardasil 9®
People at increased risk of mpox Based on risk Mpox Imvanex®
People at increased risk of gonorrhoea Based on risk Gonorrhoea Bexsero®

1 In addition to hexavalent vaccine (Infanrix hexa or Vaxelis) given at 8, 12, 16 weeks and 18 months. Take blood for HBsAg to exclude infection at 12 to 18 months.

2 Where the annual incidence of TB is >= 40/100,000 see the WHO country profile (external site).

3 Refer to annual flu Welsh Health Circular (external site) for eligibility criteria and vaccine recommendations

4 Check the Green Book Chapter: HPV (external site) for individuals requiring a 1, 2 or 3 dose schedule. 

5A sexual health clinician will assess individuals attending the sexual health clinic and advise vaccination if required

Additional vaccines for individuals with underlying medical conditions1

Medical condition Diseases protected against Vaccines required2
Asplenia, splenic dysfunction or complement disorder (Including people with coeliac disease who have splenic dysfunction, and all haemoglobinopathies such as homozygous sickle cell disease)  Meningococcal groups A, B, C, W and Y

Pneumococcal

Influenza
MenACWY
MenB

PCV13® or PCV20 (up to two years of age)3 
PPV23 or PCV20 (from two years of age)4

Annual flu vaccine5
Cochlear implants, cerebrospinal fluid leaks Pneumococcal PPV23 or PCV20 (from two years of age)4 
Chronic respiratory and heart conditions
(such as moderate  to severe asthma, chronic pulmonary disease, and heart failure)
Pneumococcal


Influenza
PPV23 or PCV20 (from two years of age)4 

Annual flu vaccine5
Chronic neurological conditions
(such as Parkinson’s or motor neurone disease, or learning disability)
Pneumococcal (only if the individual is also at increased risk of aspiration)

Influenza
PPV23 (from two years of age)4 

Annual flu vaccine5
Diabetes Pneumococcal


Influenza
PPV23 or PCV20 (from two years of age)4 

Annual flu vaccine5
Chronic kidney disease (CKD)
(including haemodialysis)
Pneumococcal (stage 4 and 5 CKD)
Influenza (stage 3, 4 and 5 CKD)
Hepatitis B (stage 4 and 5 CKD)
PPV23 or PCV20 (from two years of age)4

Annual flu vaccine5

Hepatitis B
Chronic liver conditions Pneumococcal

Influenza

Hepatitis A & B
PPV23 or PCV20 (from two years of age)4

Annual flu vaccine5

Hepatitis A & Hepatitis B
Haemophilia Hepatitis A & B Hepatitis A & B
Immunosuppression due to disease or treatment Pneumococcal

Influenza

Shingles
PCV13 or PCV20 (up to two years of age)3

PPV23 or PCV20 (from two years of age)4

Annual flu vaccine5

Shingrix (aged 18 years and over)

1 The list is not exhaustive. Other vaccines may be recommended for certain individuals. 

2 Check relevant chapter of the Green Book (external site) for specific schedule and for further detail.

3 See table 25.3 – Summary of vaccine doses for at-risk patients in the Green Book, Chapter 25 about pneumococcal on the UK Government website (external site) for further information.

4 Refer to the Green Book Chapter: Pneumococcal (external site) for detailed guidance on vaccine recommendations for this clinical risk group. PCV20 is expected to replace PPV23 in late 2025 or early 2026.​​​​​​​

5 From six months of age.​​​​​​​

6  Consider annual influenza vaccination for household members and those who care for people with these conditions.